Friday, May 5, 2023
Atrial fibrillation is common in elderly patients and is responsible for approximately a quarter of ischemic strokes many of which are cardioembolic and originate from the left atrial appendage. Oral anticoagulation most likely reduces thrombus formation in the left atrial appendage and has proven efficacy and safety in preventing ischemic stroke in patients with atrial fibrillation. However, oral anticoagulation is limited by nonadherence to prescribed medications, drug discontinuation, under dosing, and, for patients treated with vitamin K antagonists, poor control of the international normalized ratio. This CME activity will address professional challenges by reviewing the clinical data for left atrial appendage occlusion device therapy; discussing patient selection criteria; and discussing the history of device development. This innovative CME program will provide Cardiologists, Cardiology Fellows, Nurses, and Allied Health Professionals an introduction to left atrial appendage occlusion device implantation and how device and medical management can reduce the risk of stroke in non-valvular atrial fibrillation patients.
Fees may be waived for employees of The Ohio State University. To qualify phone or email the contact listed below.
Dates and Times
Start: 5/5/2023 7:30 AM
End: 5/5/2023 3:00 PM
At the conclusion of the continuing medical education activity participants should be able to:
1. Review clinical data for left atrial appendage occlusion device.
2. Identify patient selection criteria for left atrial appendage occlusion device.
3. Review implantation steps for the left atrial appendage occlusion device.
4. Describe the importance of pre-procedure cardiac CT in understanding anatomy, transseptal
access and the size of left atrial appendage occlusion device.
5. Experience hands-on training pig heart dissection or animal lab to introduce practical training
of implantation of left atrial appendage device.
6. Identify post left atrial appendage occlusion device implant oral anticoagulation treatment
and TEE follow-up.
7. Discuss current and upcoming clinical trials.
8. Review new device technologies.
9. Identify optimal transseptal puncture location during LAA occlusion device procedure.
7:00 a.m. Arrival and breakfast
7:30 Introduction and welcome
Emile Daoud, MD
7:40 Review clinical data and indications for left atrial appendage occlusion
Mahmoud Houmsse, MD
8:10 Patient selection criteria for left atrial appendage occlusion device
Ralph Augostini, MD
8:40 Mastering transseptal for successful left atrial appendage closure
Salvatore Savona, MD
9:30 Post-procedure complications and oral anticoagulation management
Emile Daoud, MD
10:00 Current and upcoming trial for LAAC device
John Hummel, MD
10:30 Live case implant
Mahmoud Houmsse, MD and Raul Weiss, MD
11:50 Lunch/Lecture: What you need to know from the cardiac CT of the LAA
Thura Harfi, MD, MPH
12:40 p.m. Peridevice leak (PDL); prevention, evaluation, and management
Muhammad Rizwan Afzal, MBBS
1:10 Keynote Lecture: Left Atrial Appendage Occlusion – Past, Present and Future
Raul Weiss, MD
1:40 Walk to Left Atrial Appendage Occlusion Device Implant Lab
1:50 Left Atrial Appendage Occlusion Device Implant Lab (Physicians only)
Michael Essandoh, MD; Mahmoud Houmsse, MD; and Raul Weiss, MD
|Allied Medical Professional||$25.00|
The Ohio State University Medical Center
Davis Heart and Lung Research Institute
170 W. 12th Avenue
Columbus, OH 43210
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.